COMBINE programme for clinical trials and medical devices endorsed by Member States
National authorities in Member States have endorsed a new strategy for the COMBINE programme, a cross-sector initiative to streamline combined studies of medicines and medical devices, including diagnostics.
The COMBINE programme will be rolled out over the coming years through seven cross-sector projects. It aims to foster collaboration between national authorities responsible for clinical trials and medical devices, as well as the Commission, European Medicines Agency, ethics committees and stakeholders such as sponsors, clinicians, and patient representatives.
Read the e-News published by EC Directorate-General for Health and Food Safety on 16 December 2024.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (12 janvier 2025). COMBINE programme for clinical trials and medical devices endorsed by Member States. ELSIBI. Consulté le 13 janvier 2026 à l’adresse https://doi.org/10.58079/132el





